Abstract:Africa CDC recently conducted a comprehensive risk ranking assessment of epidemic-prone diseases across the continent, identifying Ebola as one of the top 19 infectious diseases with the highest scores in disease severity risk and epidemic potential. The Ebolaviruses first described in the Democratic Republic of the Congo (DRC) in 1976 have left a harrowing trail across sub-Saharan Africa, triggering no less than 34 Ebola outbreaks in 11 sub-Saharan Africa countries, a statistic further compounded by the recent outbreak in Uganda in 2022. At present, the World Health Organization (WHO) has approved two Ebola vaccines, including Ervebo and two-component Zabdeno and Mvabea boost vaccines, for use by individuals above the age of 1 year, including pregnant women as per the Strategic Advisory Group of Experts on Immunization (SAGE) recommendations. The use of these vaccines has demonstrated noteworthy efficacy in safeguarding against Ebola in most African communities and frontline health workers in Ebola-endemic countries such as Sierra Leone, Guinea, and Liberia, among others. Unfortunately, the uptake of these vaccines in Ebola-endemic countries remains dishearteningly constrained despite their availability due to, among other things, the unpredictable timing of outbreaks, sub-optimal surveillance, vaccine demand volatility, palpable vaccine hesitancy, and fragile health infrastructure. Addressing these challenges requires a multifaceted approach that includes a synergy of partnerships between governments, communities, development partners, and private sector partners, such as pharmaceuticals. Recognizing that outbreaks originate and seize at the community level, the imperative of confronting hesitancy through sustained proactive community engagement and utilizing promising vaccination strategies such as ring vaccination must be encouraged. Governments must increase investments to strengthen the regulatory environment for timely access to vaccine stockpiles, robust and cost-effective Ebola vaccination programs for at-risk populations, and preventative use for the health workforce. The International Coordinating Group (ICG) on Vaccine Provision also recommends that national and international health authorities initiate vaccine access by submitting a request to the ICG. This opportunity is at no cost for GAVI-eligible countries and on a reimbursement basis for non-eligible countries. In parallel, Africa CDC is also working closely with Member States on the continent to increase availability and access to medical countermeasures, which include therapeutics, vaccines, and diagnostics, making it critical that Africa CDC is included in the ICG. This will promote timely issue profiling and resolution for increased demand for vaccine stockpiles across the continent where they are needed most as the continent moves towards enhanced health security.

Sustainable financing for vaccination towards advancing universal health coverage in the WHO African region: The strategic role of national health insurance

Sustainable financing for Immunization Agenda 2030

Progress with COVID-19 vaccination in the WHO African Region in 2021

The nature and contribution of innovative health financing mechanisms in the World Health Organization African region: A scoping review

Financing immunisation in Kenya: examining bottlenecks in health sector planning and budgeting at the decentralised level

Vaccination Communication Strategies and Uptake in Africa: A Systematic Review

Is health expenditure on immunisation associated with immunisation coverage in sub-Saharan Africa? A multicountry analysis, 2013-2017

Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets

Health financing for universal health coverage in Sub-Saharan Africa: a systematic review

Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana

Advocacy, experience sharing and action planning toward raising additional financing for primary health care: spending more and spending better towards universal health coverage

Strengthening the WHO Regional Office for Africa (WHO AFRO) COVID-19 vaccination information system

Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa

Shielding Africa, Protecting the World: Unleashing the Power of Preventative Use of Ebola Vaccines

COVID-19 vaccination in low and middle-income countries: Creating a sustainable roadmap for promoting public health intervention

Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities

Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective

Enhancing Political Will for Universal Health Coverage in Nigeria

Strengthening the Health System as a Strategy to Achieving a Universal Health Coverage in Underprivileged Communities in Africa: A Scoping Review

A rapid increase in coverage of COVID-19 vaccination, Central African Republic

Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future